Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India/United Kingdom, 2021-01-05 09:06 (1060 d 18:27 ago) – Posting: # 22174
Views: 1,858

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
22,811 posts in 4,783 threads, 1,638 registered users;
39 visitors (0 registered, 39 guests [including 14 identified bots]).
Forum time: 03:33 CET (Europe/Vienna)

Inspiration is constantly in the air.
It’s up to us to develop the sensitivity
to pick up on it. Herbie Hancock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz